Results 61 to 70 of about 89,233 (267)
Transcatheter Mitral Valve Replacement in the Transcatheter Aortic Valve Replacement Era
After the success and worldwide adoption of transcatheter aortic valve replacement (TAVR), the percutaneous replacement of a diseased mitral valve (MV) rapidly became a target for investigators and industry. The rejuvenated enthusiasm of industry in this field is also corroborated by the fact that, in 2015, ≈2.5 billion dollars were invested in MV ...
Luca Testa +5 more
openaire +4 more sources
Transcatheter Mitral Valve Repair or Replacement: Competitive or Complementary? [PDF]
Over the last two decades, transcatheter devices have been developed to repair or replace diseased mitral valves (MV). Transcatheter mitral valve repair (TMVr) devices have been proven to be efficient and safe, but many anatomical structures are not ...
Derk Frank +22 more
core +1 more source
Early Experience With Evoque Transcatheter Tricuspid Valve Replacement in Carcinoid Heart Disease
ABSTRACT Tricuspid regurgitation (TR) is nearly universal in carcinoid heart disease (CHD), but surgical replacement carries significant risk, and CHD was excluded from the landmark TRISCEND II trial. We present seven patients with CHD undergoing Evoque transcatheter tricuspid valve replacement (TTVR) at two tertiary centers.
Jackson S. Burton +3 more
wiley +1 more source
Introduction Retrograde transcatheter closure of perimembranous aneurysmal ventricular septal defects (pmVSD) can be a better option for transcatheter closure of ventricular septal defect with device placement into ventricular septal aneurysm with fewer ...
Rania Diaa Abou Shokka +2 more
doaj +1 more source
ABSTRACT The SAPIEN M3 system has been recently approved for transcatheter mitral valve replacement (TMVR). The transeptal guide sheath is used to deploy the dock, which is completely released before inserting and deploying the M3 valve using the same femoral access, transeptal puncture (TSP) and guide sheath.
Clara Fernandez‐Cordon +5 more
wiley +1 more source
Update of transcatheter valve treatment [PDF]
Transcatheter valve implantation or repair has been a very promising approach for the treatment of valvular heart diseases since transcatheter aortic valve implantation (TAVI) was successfully performed in 2002. Great achievements have been made in this field (especially TAVI and transcatheter mitral valve repair--MitraClip system) in recent years ...
Xian-bao, Liu, Jian-an, Wang
openaire +2 more sources
The Triple Wire Dual Angioseal Technique for Large Bore Femoral Access Closure
ABSTRACT There is a growing need for large‐bore femoral access across cardiac interventions. This has led to a need for more widely accessible vascular closure techniques to facilitate reliable vascular closure and wider access to these interventions.
Hilal Khan, Mohaned Egred
wiley +1 more source
Devices and methods for transcatheter retrieval of mechanical heart valve leaflets [PDF]
The present invention teaches apparatuses and methods for transcatheter removal of mechanical heart valve leaflets from a subject. The invention also teaches methods for subsequent transcatheter placement of a bioprosthesis within the annulus that ...
core
ABSTRACT Background Residual shunt is a known complication in percutaneous patent foramen ovale (PFO) closure, and moderate to large residual shunt has been associated with an increased risk of recurrent stroke. Device‐related factors, such as device size, have been associated with residual shunt, but comparative data per device type are scarce.
Jelle D. Nieuwendijk +12 more
wiley +1 more source
Transcatheter aortic valve resection: new mechanical devices [PDF]
Background To improve periprocedural outcomes of transcatheter aortic valve implantation (TAVI), transcatheter mechanical resection devices were tested for prior ablation of the aortic cusps.
Puehler, Thomas +7 more
core +1 more source

